Full-Time

Quality Control Chemist 2

MedPharm

MedPharm

Topical and transdermal drug delivery CDMO

No salary listed

Durham, NC, USA

In Person

Bachelor's, Master's

Category
Biology & Biotech (1)
Required Skills
GMP
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • A Bachelor of Science with 4–6 years of experience, or a Master of Science with 3–4 years of experience, focused in chemistry, pharmaceutics, or a related scientific discipline.
  • Two to five years of experience in a Good Manufacturing Practice laboratory setting in the pharmaceutical industry.
  • Experience with general laboratory instruments, including Fourier-transform infrared spectroscopy, particle size equipment, titration equipment, and ultraviolet-visible spectroscopy.
  • Experience with high-performance liquid chromatography testing and troubleshooting.
  • Prior experience testing raw materials or finished products in a Good Manufacturing Practice pharmaceutical environment.
  • Knowledge of Good Documentation Practices and ALCOA++ principles.
  • Proficiency in Empower, Microsoft Excel, and Microsoft Word.
  • Ability to communicate and present information in a logical and articulate manner appropriate for the audience.
  • Ability to perform work thoroughly and attend to detail using logical, organized, and methodical thinking.
Responsibilities
  • Perform testing using a variety of analytical techniques in a Good Manufacturing Practice environment for an Analytical Quality Control team in a contract development and manufacturing organization.
  • Carry out routine laboratory work as directed by management or senior laboratory personnel with minimal supervision.
  • Perform complex analyses with moderate supervision.
  • Conduct routine analytical experiments using established analytical methods and procedures.
  • Enter data into reports as directed by senior laboratory personnel.
  • Verify simple transcription processes, including checking calculation accuracy and reviewing daily equipment verifications for compliance.
  • Support investigations of out-of-specification, out-of-trend, and aberrant results and troubleshooting.
  • Review and maintain laboratory notebooks.
  • Process and submit collected data for review in a timely manner.
  • Assist with root-cause determination and report writing for investigations of out-of-specification, out-of-trend, and aberrant results and troubleshooting.
  • Maintain laboratory inventory of chemicals, standards, and consumables and order materials as necessary.
  • Revise existing methods, standard operating procedures, and work instructions as needed.
Desired Qualifications
  • Technical report writing proficiency.

MedPharm is a contract development and manufacturing organization specializing in topical, transdermal, and mucosal drug delivery. It provides end-to-end services from formulation development through clinical and commercial manufacturing, including analytical testing and regulatory support, and operates proprietary delivery platforms such as MedSpray, MedTherm, and AquaRMed. Its capabilities cover dermal, pulmonary, nasal, ophthalmic, and other mucosal routes, combining research services with a patent portfolio to support product lifecycle needs. In 2024 it merged with Tergus Pharma to expand into hormone-based and highly potent drugs, with the goal of helping pharmaceutical and biotech customers move from early formulation to scalable, reliable manufacturing for clinical and commercial use.

Company Size

N/A

Company Stage

Grant

Total Funding

$390K

Headquarters

Guildford, United Kingdom

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2025 CEO Bill Humphries signals post-merger growth execution and commercial discipline.
  • The Durham $4 million expansion created space for over 100 skilled hires in RTP.
  • Palvella's positive March 2026 Phase 3 readout and Purna partnership strengthen sponsor validation.

What critics are saying

  • MedPharm depends on niche topical spending; a sponsor slowdown hits utilization fast in 2025-2026.
  • The 2024 merger left some Tergus leaders exiting, creating integration and execution risk.
  • Topical CDMO giants and captive pharma plants can compress margins and steal repeat programs.

What makes MedPharm unique

  • MedPharm remains the topical and transepithelial CDMO specialist after the 2024 Tergus merger.
  • Durham and Guildford sites give MedPharm integrated development, clinical manufacturing, and commercial production.
  • August 2026 Olink CSP status adds proprietary proteomics beyond formulation and in vitro testing.

Help us improve and share your feedback! Did you find this helpful?

Company News

FinSMEs
Jul 9th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a Guildford, UK-based topical and transdermal Contract Development and Manufacturing Organization (CDMO) and Ampersand Capital Partners portfolio company, announced a merger with Tergus Pharma, a Research Triangle Park, NC-based end-to-end contract service provider and a Great Point Partners portfolio company

FinSMEs
Jul 8th, 2024
MedPharm and Tergus Pharma Merge

MedPharm, a UK-based CDMO, has merged with Tergus Pharma, a US-based contract service provider. The combined entity will operate under the MedPharm name, offering end-to-end drug development and manufacturing services. Michael Kane, Tergus Pharma CEO, will become CEO of MedPharm, while Patrick Walsh remains Executive Chairman. Great Point Partners retains a significant minority stake, with Ampersand Capital Partners and Bourne Partners Strategic Capital holding majority ownership.